Alphatec Holdings [ATEC] vs Globus Medical [GMED] Detailed Stock Comparison

Alphatec Holdings

NASDAQ
Loading...

Globus Medical

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Alphatec Holdings wins in 6 metrics, Globus Medical wins in 12 metrics, with 0 ties. Globus Medical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricAlphatec HoldingsGlobus MedicalBetter
P/E Ratio (TTM)-12.3523.44Alphatec Holdings
Price-to-Book Ratio86.171.90Globus Medical
Debt-to-Equity Ratio1,238.292.83Globus Medical
PEG Ratio1.790.04Globus Medical
EV/EBITDA-167.8210.96Alphatec Holdings
Profit Margin (TTM)-24.33%13.58%Globus Medical
Operating Margin (TTM)-6.19%17.33%Globus Medical
EBITDA Margin (TTM)N/A17.33%N/A
Return on Equity-376.89%8.62%Globus Medical
Return on Assets (TTM)-7.61%5.82%Globus Medical
Free Cash Flow (TTM)$-137.79M$405.21MGlobus Medical
1-Year Return164.08%-14.74%Alphatec Holdings
Price-to-Sales Ratio (TTM)3.033.11Alphatec Holdings
Enterprise Value$2.52B$8.06BGlobus Medical
EV/Revenue Ratio3.693.07Globus Medical
Gross Profit Margin (TTM)69.58%66.62%Alphatec Holdings
Revenue per Share (TTM)$5$19Globus Medical
Earnings per Share (Diluted)$-1.13$2.58Globus Medical
Beta (Stock Volatility)1.061.12Alphatec Holdings
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Alphatec Holdings vs Globus Medical Stock Performance Analysis

Loading Price Chart...

Alphatec Holdings
Globus Medical
Alphatec Holdings Stock Overview | Globus Medical Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Alphatec Holdings-2.58%-7.80%-16.77%24.43%35.86%50.11%
Globus Medical-0.51%6.65%1.04%7.50%-14.95%-26.47%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Alphatec Holdings164.08%50.11%34.52%206.31%-54.67%-85.69%
Globus Medical-14.74%-0.99%8.69%158.80%345.70%345.70%

News Based Sentiment: Alphatec Holdings vs Globus Medical

Alphatec Holdings

News based Sentiment: MIXED

October presented a mixed bag for Alphatec, with stock declines and insider selling countered by oversold signals and upcoming earnings. The Q3 report on October 29th is a key catalyst that will determine the overall investment narrative, making this a moderately important month for the company.

View Alphatec Holdings News Sentiment Analysis

Globus Medical

News based Sentiment: MIXED

Globus Medical is showing strong financial growth and innovation, but a declining stock price and decreasing ROIC create a mixed investment picture. The positive analyst ratings and strong market position suggest potential, but investors should carefully monitor key performance indicators and market signals.

View Globus Medical News Sentiment Analysis

Performance & Financial Health Analysis: Alphatec Holdings vs Globus Medical

MetricATECGMED
Market Information
Market Cap i$2.22B$8.17B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i1,642,6971,666,320
90 Day Avg. Volume i1,921,7191,314,997
Last Close$13.60$60.17
52 Week Range$4.88 - $16.70$51.79 - $94.93
% from 52W High-18.56%-36.62%
All-Time High$105.60 (Jun 12, 2006)$94.93 (Jan 27, 2025)
% from All-Time High-87.12%-36.62%
Growth Metrics
Quarterly Revenue Growth0.28%0.18%
Quarterly Earnings Growth0.27%5.39%
Financial Health
Profit Margin (TTM) i-0.24%0.14%
Operating Margin (TTM) i-0.06%0.17%
Return on Equity (TTM) i-3.77%0.09%
Debt to Equity (MRQ) i1,238.292.83
Cash & Liquidity
Book Value per Share (MRQ)$0.16$31.81
Cash per Share (MRQ)$1.06$1.70
Operating Cash Flow (TTM) i$15.69M$669.16M
Levered Free Cash Flow (TTM) i$21.17M$456.11M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Alphatec Holdings vs Globus Medical

MetricATECGMED
Price Ratios
P/E Ratio (TTM) i-12.3523.44
Forward P/E i-21.4817.68
PEG Ratio i1.790.04
Price to Sales (TTM) i3.033.11
Price to Book (MRQ) i86.171.90
Market Capitalization
Market Capitalization i$2.22B$8.17B
Enterprise Value i$2.52B$8.06B
Enterprise Value Metrics
Enterprise to Revenue i3.693.07
Enterprise to EBITDA i-167.8210.96
Risk & Other Metrics
Beta i1.061.12
Book Value per Share (MRQ) i$0.16$31.81

Financial Statements Comparison: Alphatec Holdings vs Globus Medical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ATECGMED
Revenue/Sales i$169.18M$598.12M
Cost of Goods Sold i$53.18M$195.40M
Gross Profit i$116.00M$402.72M
Research & Development i$16.58M$33.06M
Operating Income (EBIT) i$-31.71M$98.06M
EBITDA i$-10.19M$160.92M
Pre-Tax Income i$-51.97M$103.67M
Income Tax i$-64,000$28.21M
Net Income (Profit) i$-51.91M$75.46M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ATECGMED
Cash & Equivalents i$153.24M$461.27M
Total Current Assets i$434.89M$1.71B
Total Current Liabilities i$157.87M$384.70M
Long-Term Debt i$572.40M$81.69M
Total Shareholders Equity i$-85.94M$4.09B
Retained Earnings i$-1.33B$1.04B
Property, Plant & Equipment i$320.90M$1.06B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ATECGMED
Operating Cash Flow i$-23.48M$193.84M
Capital Expenditures i$-9.93M$-36.10M
Free Cash Flow i$-16.65M$136.20M
Debt Repayment i$-321.03M$-449.99M
Common Stock Repurchase i$-3.00M$-190.45M

Short Interest & Institutional Ownership Analysis

MetricATECGMED
Shares Short i12.33M6.59M
Short Ratio i6.086.55
Short % of Float i0.10%0.07%
Average Daily Volume (10 Day) i1,642,6971,666,320
Average Daily Volume (90 Day) i1,921,7191,314,997
Shares Outstanding i144.13M137.42M
Float Shares i116.52M111.74M
% Held by Insiders i0.21%0.01%
% Held by Institutions i0.69%1.03%

Dividend Analysis & Yield Comparison: Alphatec Holdings vs Globus Medical

MetricATECGMED
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A